论文信息 - Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody: A phase 1, open-label study in advanced malignancies - 字舞流文

Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody: A phase 1, open-label study in advanced malignancies

O. Hamid | J. Gray | L. Chow | R. Sanborn | M. Gribbin | Chelsea M. Black | J. Karakunnel | J. McDevitt | S. Marshall